test

Developmental Therapeutics

Vincent T DeVita Jr MD

Amy and Joseph Perella Professor of Medicine (Medical Oncology) and Professor of Epidemiology (Chronic Diseases)

Biographical Info

Dr. Vincent DeVita, the Amy and Joseph Perella Professor of Medicine at the Yale Cancer Center and Professor of Epidemiology and Public Health, was the Director of the Yale Cancer Center from 1993 to 2003. He spent the early part of his career at the National Cancer Institute (NCI), and in 1980, the President of the United States appointed him director of the NCI and the National Cancer Program, a position he held until 1988. From 1988 until be returned to Yale in 1993, he was Physician-in-Chief and Attending Physician at Memorial Sloan Kettering Cancer Center and a member of the Program of Molecular Pharmacology. Dr. DeVita has earned international recognition for his accomplishments as a pioneer in the field of Oncology. While at the NCI, he was instrumental in developing combination chemotherapy programs that ultimately led to an effective regimen of curative chemotherapy for Hodgkin's disease and diffuse large cell lymphomas. Along with colleagues at the NCI, he developed the four-drug combination, known by the acronym MOPP, which increased the cure rate for patients with advanced Hodgkin's disease from nearly zero to over 70%. In addition, in collaboration with Dr. George Canellos, he developed the combination chemotherapy CMF, which still remains a useful therapy for breast cancer. He earned his Bachelor of Science degree from the College of William and Mary in 1957. He was awarded his M.D. degree with distinction from the George Washington University School of Medicine in 1961. Dr. DeVita currently serves on the editorial boards of numerous scientific journals and is the author or co-author of more than 450 scientific articles. He is one of the three editors of "Cancer: Principles and Practice of Oncology" and serves as the Editor-in-Chief of The Cancer Journal and Nature Reviews Clinical Oncology.


International Activity

  • Cancer: Principles and Practices of Oncology
    United States (2008)
    Professor DeVita is one of three editors of CANCER: Principles &Practices of Oncology, coming into its tenth edition. CANCER is a comprehensive textbook in the field of cancer medicine; it is the most widely-read text on cancer in the world (and notably in Europe, India, and Asia). The textbook is published by Lippincott, Williams, and Wilikins.
  • Oncology, Nature Clinical Practice
    London, United Kingdom (2008 - 2015)
    Professor DeVita is an editor of Nature Reviews Clinical Oncology (NRCO), a journal by Nature Publishing Group. NRCO is based in London, with international leadership.

Education & Training

M.D.
George Washington University (1961)
Resident
Yale-New Haven Hospital
Senior Resident
George Washington U, DC General Hospital, Medicine (1962 - 1963)
Fellow
National Cancer Institute, National Institute of Health, Medical Oncology/Hematology (1963 - 1965)
Resident Intern
Univeristy of Michigan Medical Center

Honors & Recognition

  • Fellow of the American Association for Cancer Research (FAACR)
    AACR (2014)
  • Amy and Joseph Perella Chair to be named Vincent T. DeVita Professor of Medicine upon his retirement.
    Yale Cancer Center (2004)
  • Giants of Cancer Care 2013
    OncLive (2013)
  • President American Cancer Society
    ACS (2012)
  • Fellow of the American Society of Clinical Oncology (FASCO)
    ASCO (2012)
  • Honorary Life Member
    American Cancer Society (2013)
  • Distinguished Medical Science Award
    Friends of the National Library of Medicine, Washington DC (2009)
  • Awarded Honoris Causa in Medicine Degree
    National University of Athens, Greece (2009)
  • ASCO Statesman Award
    American Society of Clinical Oncology (2007)
  • FREDDIE Award, a Public Service Award.
    International Health & Medical Media Awards (2007)
  • Elected, European Academy of Sciences
    European Academy of Sciences (2002)

Edit Profile